Related Experiment Video
Updated: Jul 16, 2026

12:15
Generation of Monoclonal Antibodies Against Natural Products
Published on: April 6, 2019
Design and Synthesis of Hesperidin Derivatives With Anti-Inflammatory Potential
Hong-Yue Ma1, Xian-Fei Chen1, Jing Wei1
1Hubei Key Laboratory of Natural Products Research and Development, College of Biological and Pharmaceutical Sciences, China Three Gorges University, Yichang, China.
Chemistry & Biodiversity
|July 14, 2026
Summary
Researchers synthesized novel hesperidin derivatives to find better anti-inflammatory drugs. Compound B8 showed strong inhibition of nitric oxide (NO) production in macrophages, offering a new strategy for developing hesperidin-based anti-inflammatory agents.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Computational Chemistry
Background:
- Hesperidin, a citrus flavonoid, possesses diverse pharmacological activities.
- There is a need for novel anti-inflammatory compounds with improved efficacy.
- Developing new hesperidin derivatives can lead to potent therapeutic agents.
Purpose of the Study:
- To design and synthesize novel hesperidin derivatives.
- To evaluate the anti-inflammatory potential of these derivatives.
- To investigate the molecular interactions of promising compounds.
Main Methods:
- Synthesis of 22 hesperidin derivatives incorporating fatty and cinnamic acid groups.
- Assessment of inhibitory effects on lipopolysaccharide (LPS)-induced nitric oxide (NO) production in RAW264.7 macrophages.
- Molecular docking simulations with the NLRP3 protein and quantum chemical calculations.
Main Results:
- Compound B8 exhibited the most potent inhibition of NO production (IC50 = 10.4 ± 0.7 µM) without significant cytotoxicity.
- Molecular docking revealed a favorable binding energy of -8.39 kcal/mol for compound B8 with the NLRP3 protein.
- Quantum chemical calculations provided insights into the binding interactions.
Conclusions:
- The synthesized hesperidin derivatives, particularly B8, show significant anti-inflammatory potential.
- Compound B8 represents a promising lead for the development of novel anti-inflammatory drugs.
- The study offers a valuable structural design strategy for future hesperidin-based drug discovery.
Related Concept Videos
Antibody Structure
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

